Asian Journal of Innovation and Policy

Asian Society for Innovation and Policy (아시아기술혁신학회)
권호 표지
DOI QR코드

DOI QR Code

Development of Molecular Diagnostic Innovation System in India: Role of Scientific Institutions

  • Singh, Nidhi (Department of Science & Technology, Ministry of Science & Technology)
  • Received : 2022.01.09
  • Accepted : 2022.04.11
  • Published : 2022.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

The study attempts to examine the system-building activities of scientific institutions in developing the Molecular Diagnostic (MDs) Innovation System in India. Scientific Institutions are the precursor of any technological development with their capabilities in generating new ideas. MDs are advanced and accurate diagnostic technology with considerable scope to serve the diagnostic needs and requirements of the healthcare system. We adopted a System framework and analyzed the development of MDs in terms of the Technological Innovation System (TIS) functions, and the systematic challenges are assessed through the System Failure Framework (SFF). Based on the secondary and primary survey of prominent science base actors, the study finds that the role of government is crucial for facilitating technological development within a science base through the mobilization of resources. In India, the MDs technological development gained significant momentum over the last decade with the development of specialized human resources and dedicated research institutes. However, we do find that the innovative capabilities in attaining need-based TIS are sub-optimal owning to the specific diagnostic needs of highly burdened diseases in the society. The system analysis reveals that the TIS functions are underperforming because of the absence of a well-defined funding mechanism and goal-oriented targeted policy regime of the government. Since MDs have a transformative effect on the present healthcare system, we argue that the government has to address the system-based challenges and issues for developing a need-based technological innovation system for MDs in the country.

Keywords

References

  1. AdvaMedDx & DxInsights. (2013). Introduction to Molecular Diagnostics: The Essentials of Diagnostics Series, https://dx.advamed.org.
  2. Bergek, Jacobsson, and Sanden. (2008). Legitimation and Development of Positive Externalities: Two key Processes in the Formation Phase of Technological Innovation Systems, Technology Analysis & Strategic Management, 20 (5), 575-592. https://doi.org/10.1080/09537320802292768
  3. Kennedy. (1994). The relationship between Science and Technology. Research Policy, 23, 477-486. https://doi.org/10.1016/0048-7333(94)01001-3
  4. Carlsson and Stankiewicz. (1991). On the Nature, Function and Composition of Technological Systems, Journal of Evolutionary Economics, 1 (2), 93-118. https://doi.org/10.1007/BF01224915
  5. Constance. (2010). The future of Molecular Diagnostics; Innovative Technologies Driving Market Opportunities in Personalized Medicine, Business Insights Ltd.
  6. Garcia. (2000). Science and Technology and their role in Human Health in Developing Countries, Mem Inst Oswaldo Cruz, Rio de Janeiro,95 (1), 5-7. https://doi.org/10.1590/S0074-02762000000700001
  7. Ghosh et al. (1997). Business Opportunities in Medical Diagnostics in India: A market report. Biotech Consortium India Limited.
  8. Guglielmi. (2020). Researchers are scrambling to find new ways to diagnose the coronavirus and churn out millions of tests a week - a key step in returning to relative normality, Nature, 583, 506-509. https://doi.org/10.1038/d41586-020-02140-8
  9. Mierlo, Arkesteijn, and Leeuwis. (2010). Enhancing the Reflexivity of System Innovation Projects with System Analyses, American Journal of Evaluation, 31(2), 143-161. https://doi.org/10.1177/1098214010366046
  10. Musiolik et al. (2012). Networks and Network Resources in Technological Innovation Systems: Towards a Conceptual Framework for system building,Technological Forecasting and Social Change, 79(6), 1032-1048. https://doi.org/10.1016/j.techfore.2012.01.003
  11. OECD. (1997). National Innovation Systems, Paris.
  12. Poste. (2001). Molecular Diagnostics: A Powerful New Component of the Healthcare Value Chain, Expert Rev. Mol. Diag, 1 (1).
  13. Singh and Abrol. (2017). In-Vitro Diagnostics (IVDs) Innovations for Resource-Poor Settings: The Indian Experience, African Journal of Science Technology Innovation and Development, 9 (5), 617-636. https://doi.org/10.1080/20421338.2017.1359465
  14. Woolthuis et al. (2005). A System Failure Framework for Innovation Policy Design, Technovation, 25 (6), 609-619. https://doi.org/10.1016/j.technovation.2003.11.002
  15. ICMR. (2020). Advisory: Newer Additional Strategies for COVID-19 Testing, 2020. https://www.icmr.gov.in/pdf/covid/strategy/New_additional_Advisory_23062020_3.pdf
  16. ICMR. (2021) Role of evidence-based &well-researched guidance is vital in defeating the pandemic, e-Samvaad. https://www.icmr.gov.in/pdf/press_realease_files/Newsletter_English_May_2021.pdf.